TECNALIA is working on improving advanced technologies for remote manipulation and tactile feedback to the surgeon
This technology-based start-up company develops and markets medical devices for the rehabilitation of stroke patients and those affected by neuromuscular diseases
FESIA has closed its first round of financing with 750 thousand euros, which was launched through Capital Cell, the crowdfunding platform that specialises in biomedicine and medical devices
: its first two products for the rehabilitation of stroke patients will enter the market, making it a benchmark company for functional electrical stimulation.
FESIA’s shareholders including the FIK initiative, Basque Venture Capital Management, VUSA, TECNALIA and private investors aim to improve the quality of life of stroke patients and those affected by other neuromuscular diseases in all stages of their rehabilitation process, using medical devices based on new functional electrical stimulation technology.
Functional electrical stimulation (FES) is a technology used by specialists due to the benefits it provides to the rehabilitation process: it improves walking dynamics and balance, prevents muscle atrophy and the technology is well accepted by patients. Current FES devices have limitations and require expert knowledge to use them well.
The technology-based company, a TECNALIA spin-off with the support of the FIK initiative, has developed technology that through automation and simplification facilitates the use of functional electrical stimulation: therefore a greater number of specialists can take advantage of its benefits and their patients can have more efficient rehabilitation.